Table 2.

Bivariate Spearman correlation between calprotectin and other biochemical markers and metabolic features in patients with and without metabolic syndrome

	Metabolic syndrome (n = 243)		No metabolic syndrome (n = 62)
	ρ	P	ρ	P
Age (years)	−0.179	0.005	−0.138	0.294
Weight (kg)	0.199	0.002	0.317	0.014
Height (m)	−0.129	0.046	−0.211	0.106
BMI (kg/m2)	0.252	<0.001	0.446	<0.001
Waist circumference (cm)	0.237	0.001	0.257	0.047
Hip circumference (cm)	0.230	<0.001	0.285	0.027
Diabetes duration (years)	−0.172	0.008	0.092	0.486
CIMT (mm)	−0.114	0.079	−0.168	0.200
Fasting p-glucose (mmol/L)	−0.148	0.021	−0.069	0.601
HbA1c (%)	−0.037	0.564	−0.052	0.691
Fasting C-peptide (pmol/L)	0.081	0.212	0.177	0.176
Fasting insulin (pmol/L)	0.169	0.009	0.247	0.057
Total cholesterol conc. (mmol/L)	−0.072	0.268	0.084	0.523
LDL-cholesterol conc. (mmol/L)	0.002	0.978	0.131	0.318
HDL-cholesterol conc. (mmol/L)	−0.151	0.019	−0.259	0.045
Triglycerides (mmol/L)	0.018	0.779	0.289	0.025
Creatinine (μmol/L)	0.000	0.995	0.022	0.868
hs-CRP (mg/L)	0.415	<0.001	0.346	0.007
HOMA-IR	0.110	0.088	0.169	0.197
SSS	0.136	0.035	0.222	0.088

Statistical significant results are shown in bold.